<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE LIFECORE BIOMEDICAL, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1 <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> JUN-30-2000 <PERIOD-START> JUL-01-1999 <PERIOD-END> SEP-30-1999 <CASH> 364,000 <SECURITIES> 0 <RECEIVABLES> 6,231,000 <ALLOWANCES> 382,000 <INVENTORY> 23,778,000 <CURRENT-ASSETS> 22,787,000 <PP&E> 41,979,000 <DEPRECIATION> 10,118,000 <TOTAL-ASSETS> 69,558,000 <CURRENT-LIABILITIES> 7,269,000 <BONDS> 6,695,000 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 124,000 <OTHER-SE> 55,470,000 <TOTAL-LIABILITY-AND-EQUITY> 69,558,000 <SALES> 7,140,000 <TOTAL-REVENUES> 7,140,000 <CGS> 2,963,000 <TOTAL-COSTS> 6,794,000 <OTHER-EXPENSES> 20,000 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 227,000 <INCOME-PRETAX> 114,000 <INCOME-TAX> 0 <INCOME-CONTINUING> 114,000 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 114,000 <EPS-BASIC> .01 <EPS-DILUTED> .01